Is Tirzepatide FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. Each entry is based on publicly available information from the U.S. Food and Drug Administration and other authoritative sources. This page explains whether tirzepatide is FDA approved and how it is commonly categorized.
Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist used in FDA-approved medications for specific indications, including type 2 diabetes and chronic weight management under certain brand-name products.
FDA Status Details
Tirzepatide is classified as FDA Approved when used in approved branded products and approved dosage forms. Approval status depends on the specific product, manufacturer, formulation, dosage form, and intended use.
Brand Names & Variants
FDA-approved tirzepatide brand-name products include Mounjaro and Zepbound depending on the product form and approved indication.
Compounded & Private Label Considerations
Compounded tirzepatide products are not FDA approved. Some compounded, privately labeled, or online-marketed products may not be reviewed by the FDA for safety, effectiveness, or quality in the same way as approved medications.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.